Report Scope
The report’s scope includes an overview of the global market for anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading market players’ profiles, marketed products, pipeline products, and recent market activities are provided. The report details market for anti-obesity drugs based on drug type, distribution channel, and region. Based on drug type, the market is segmented into prescription drugs, and over-the-counter (OTC) drugs. The market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies on the basis of distribution channel. Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).
Report Includes
- An overview of the current and future global markets for anti-obesity drugs
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast for the global anti-obesity drugs market, and corresponding market share analysis based on drug type, distribution channel, and region
- Overview of ESG outlook with emphasis on sustainability trends and factors on anti-obesity drugs market
- Identification of the major vendors in the global market for anti-obesity drugs, along with an analysis of the structure of this industry, including company market shares, M&A deals and venture fundings
- Profiles of the leading global players
Table of Contents
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Chapter 4 Global Market for Anti-obesity Drugs by Type
Chapter 5 Global Market for Anti-obesity Drugs by Distribution Channel
Chapter 6 Global Market for Anti-obesity Drugs by Region
Chapter 7 ESG Developments
Chapter 8 Competitive Landscape
Chapter 9 Company Profiles
List of Tables
List of Figures
Executive Summary
The goal of this study is to determine the current market scenario for anti-obesity drugs, its types, and assess the distribution channels as well as to gauge the market’s growth potential during the forecast period of 2023-2028. The research explores market trends, approved anti-obesity drugs in the market, and product pipeline that is set to significantly impact the growth of the market in the coming five to ten years for anti-obesity drugs. The study provides a comprehensive analysis of the current market for antiobesity drugs and predicts the future direction of the market.Companies Mentioned
- Altimmune Inc.
- Boehringer Ingelheim International Gmbh
- Currax Pharmaceuticals Llc
- Eli Lilly And Co.
- F. Hoffmann-La Roche Ag
- Glaxosmithkline Plc
- Novo Nordisk A/S
- Pfizer Inc.
- Rhythm Pharmaceuticals, Inc.
- Vivus Llc
